According to Sientra's latest financial reports the company has $15.02 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $26.07 M | -49.64% |
2021-12-31 | $51.77 M | -5.81% |
2020-12-31 | $54.96 M | -37.26% |
2019-12-31 | $87.6 M | 0.82% |
2018-12-31 | $86.89 M | 226.84% |
2017-12-31 | $26.58 M | -60.44% |
2016-12-31 | $67.21 M | -40.42% |
2015-12-31 | $0.11 B | 16.62% |
2014-12-31 | $96.72 M | 894.95% |
2013-12-31 | $9.72 M | -75.2% |
2012-12-31 | $39.2 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Edwards Lifesciences EW | $1.64 B | 10,844.36% | ๐บ๐ธ USA |
iRadimed IRMD | $49.76 M | 231.17% | ๐บ๐ธ USA |
Cardiovascular Systems CSII | $0.13 B | 778.49% | ๐บ๐ธ USA |
West Pharmaceutical WST | $0.60 B | 3,905.06% | ๐บ๐ธ USA |